PP1A在肿瘤发生发展过程中的作用及研究进展

doi:10.3760/cma.j.issn.1007-1245.2023.23.004

摘要/Abstract

摘要：

蛋白磷酸酶是一组在人类细胞中广泛存在并催化已经磷酸化的蛋白质分子发生去磷酸化反应的一类酶分子。而磷酸蛋白磷酸酶催化亚基超家族是一组主要使丝氨酸/苏氨酸残基去磷酸化的蛋白磷酸酶，其中蛋白磷酸酶1（protein phosphatase-1，PP1）参与了真核生物大部分的去磷酸化反应，并参与调节多种生物活动。由PPP1CA基因编码的PP1催化亚基α（catalytic subunit alpha of protein phosphatase-1，PP1A）是修饰PP1最重要的一种亚型，在多种肿瘤生存和转移中起着重要作用，但其在肿瘤中也会表现出抑制作用，这使其可能成为肿瘤治疗的新靶标。因此，本文旨在对PP1A在多种肿瘤中关键作用进行综述，并针对其作为肿瘤治疗的新靶标潜力进行评价。

关键词:

蛋白磷酸酶, PP1A, PPP1CA, 癌症, 进展

Abstract:

Protein phosphatases are a group of proteins that widely exist in human cells and catalyze protein dephosphorylation. The phosphoprotein phosphatase catalytic subunits (PPPCs) superfamily is a group of protein phosphatases that primarily dephosphorylate serine/threonine residues. The protein phosphatase-1 (PP1) is involved in most eukaryotic phosphorylation reaction and participates in regulating a variety of biological activities. The catalytic subunit α of PP1 (PP1A) is the most important subtype of the PP1 catalytic subunit encoded by PPP1CA, which plays an important role in the survival and metastasis of a variety of tumors, but it also exhibits inhibitory effect in tumors, which makes it a possible new target for tumor treatment. Therefore, this article aims to review the key role of PP1A in a variety of tumors and evaluate its potential as a novel target for tumor therapy.

Key words:

Protein phosphatase, PP1A, PPP1CA, Cancer, Progress

司航王娜娜刘素素张骞.

PP1A在肿瘤发生发展过程中的作用及研究进展 [J]. 国际医药卫生导报, 2023, 29(23): 3336-3340.

Si Hang, Wang Nana, Liu Susu, Zhang Qian.

Role of PP1A in cancer and research progress [J]. International Medicine and Health Guidance News, 2023, 29(23): 3336-3340.

参考文献

[1] Ferlay J, Colombet M, Soerjomataram I, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods[J].Int J Cancer,2019,144(8):1941-1953.DOI:10.1002/ijc.31937.
[2] Barford D. Protein phosphatases[J].Curr Opin Struct Biol,1995,5(6):728-734.DOI:10.1016/0959-440x(95)80004-2.
[3] Felgueiras J, Jerónimo C, Fardilha M. Protein phosphatase 1 in tumorigenesis: is it worth a closer look?[J].Biochim Biophys Acta Rev Cancer,2020,1874(2):188433.DOI:10.1016/j.bbcan.2020.188433.
[4] Lv XB, Liu CY, Wang Z, et al. PARD3 induces TAZ activation and cell growth by promoting LATS1 and PP1 interaction[J].EMBO Rep,2015,16(8):975-985.DOI:10.15252/embr.201439951.
[5] Kolupaeva V, Janssens V. PP1 and PP2A phosphatases--cooperating partners in modulating retinoblastoma protein activation[J].FEBS J,2013,280(2):627-643.DOI:10.1111/j.1742-4658.2012.08511.x.
[6] Cai B, Ma W, Wang X, et al. Targeting LncDACH1 promotes cardiac repair and regeneration after myocardium infarction[J].Cell Death Differ,2020,27(7):2158-2175.DOI:10.1038/s41418-020-0492-5.
[7] Addison WN, Pellicelli M, St-Arnaud R. Dephosphorylation of the transcriptional cofactor NACA by the PP1A phosphatase enhances cJUN transcriptional activity and osteoblast differentiation[J].J Biol Chem,2019,294(20):8184-8196.DOI:10.1074/jbc.RA118.006920.
[8] Grech G, Baldacchino S, Saliba C, et al. Deregulation of the protein phosphatase 2A, PP2A in cancer: complexity and therapeutic options[J].Tumour Biol,2016,37(9):11691-11700.DOI:10.1007/s13277-016-5145-4.
[9] Kauko O, Westermarck J. Non-genomic mechanisms of protein phosphatase 2A (PP2A) regulation in cancer[J].Int J Biochem Cell Biol,2018,96:157-164.DOI:10.1016/j.biocel.2018.01.005.
[10] Baskaran R, Velmurugan BK. Protein phosphatase 2A as therapeutic targets in various disease models[J].Life Sci,2018,210:40-46.DOI:10.1016/j.lfs.2018.08.063.
[11] Dacol EC, Wang S, Chen Y, et al. The interaction of SET and protein phosphatase 2A as target for cancer therapy[J].Biochim Biophys Acta Rev Cancer,2021,1876(1):188578.DOI:10.1016/j.bbcan.2021.188578.
[12] Liu CW, Wang RH, Berndt N. Protein phosphatase 1alpha activity prevents oncogenic transformation[J].Mol Carcinog,2006,45(9):648-56.DOI:10.1002/mc.20191.
[13] Lu Z, Wan G, Guo H, et al. Protein phosphatase 1 inhibits p53 signaling by dephosphorylating and stabilizing Mdmx[J].Cell Signal,2013,25(4):796-804.DOI:10.1016/j.cellsig.2012.12.014.
[14] Egger JV, Lane MV, Antonucci LA, et al. Dephosphorylation of the Retinoblastoma protein (Rb) inhibits cancer cell EMT via Zeb[J].Cancer Biol Ther,2016,17(11):1197-1205.DOI:10.1080/15384047.2016.1235668.
[15] Valdimarsdottir G, Goumans MJ, Itoh F, et al. Smad7 and protein phosphatase 1alpha are critical determinants in the duration of TGF-beta/ALK1 signaling in endothelial cells[J].BMC Cell Biol,2006,7:16.DOI:10.1186/1471-2121-7-16.
[16] Xie W, Sun Y, Zeng Y, et al. Comprehensive analysis of PPPCs family reveals the clinical significance of PPP1CA and PPP4C in breast cancer[J].Bioengineered,2022,13(1):190-205.DOI:10.1080/21655979.2021.2012316.
[17] Winter SL, Bosnoyan-Collins L, Pinnaduwage D, et al. The interaction of PP1 with BRCA1 and analysis of their expression in breast tumors[J].BMC Cancer,2007,7:85.DOI:10.1186/1471-2407-7-85.
[18] Yoshimaru T, Ono M, Bando Y, et al. A-kinase anchoring protein BIG3 coordinates oestrogen signalling in breast cancer cells[J].Nat Commun,2017,8:15427.DOI:10.1038/ncomms15427.
[19] Yang J, Li B, He QY. Significance of prohibitin domain family in tumorigenesis and its implication in cancer diagnosis and treatment[J].Cell Death Dis,2018,9(6):580.DOI:10.1038/s41419-018-0661-3.
[20] Hall EH, Daugherty AE, Choi CK, et al. Tensin1 requires protein phosphatase-1alpha in addition to RhoGAP DLC-1 to control cell polarization, migration, and invasion[J].J Biol Chem,2009,284(50):34713-24722.DOI:10.1074/jbc.M109.059592.
[21] Bollig A, Xu L, Thakur A, et al. Regulation of intracellular calcium release and PP1alpha in a mechanism for 4-hydroxytamoxifen-induced cytotoxicity[J].Mol Cell Biochem,2007,305(1-2):45-54.DOI:10.1007/s11010-007-9526-2.
[22] Prowatke I, Devens F, Benner A, et al. Expression analysis of imbalanced genes in prostate carcinoma using tissue microarrays[J].Br J Cancer,2007,96(1):82-88.DOI:10.1038/sj.bjc.6603490.
[23] Felgueiras J, Lobo J, Camilo V, et al. PP1 catalytic isoforms are differentially expressed and regulated in human prostate cancer[J].Exp Cell Res,2022,418(2):113282.DOI:10.1016/j.yexcr.2022.113282.
[24] Chen M, Wan L, Zhang J, et al. Deregulated PP1α phosphatase activity towards MAPK activation is antagonized by a tumor suppressive failsafe mechanism[J].Nat Commun,2018,9(1):159.DOI:10.1038/s41467-017-02272-y.
[25] Yan G, Ru Y, Yan F, et al. MIIP inhibits the growth of prostate cancer via interaction with PP1α and negative modulation of AKT signaling[J].Cell Commun Signal,2019,17(1):44.DOI:10.1186/s12964-019-0355-1.
[26] Liu X, Han W, Gulla S, et al. Protein phosphatase 1 suppresses androgen receptor ubiquitylation and degradation[J].Oncotarget,2016,7(2):1754-1764.DOI:10.18632/oncotarget.6434.
[27] Chen PC, Li C, Wang D, et al. PP-1α and PP-1γ display antagonism and differential roles in tumorigenicity of lung cancer cells[J].Curr Mol Med,2013,13(1):220-227.
[28] Chen JM, Chen KC, Chiu SC, et al. Differential contribution of protein phosphatase 1α to cell transformation of different cell types[J].Oncol Rep,2019,42(4):1598-1608.DOI:10.3892/or.2019.7272.
[29] Verdugo-Sivianes EM, Navas L, Molina-Pinelo S, et al. Coordinated downregulation of Spinophilin and the catalytic subunits of PP1, PPP1CA/B/C, contributes to a worse prognosis in lung cancer[J].Oncotarget,2017,8(62):105196-105210.DOI:10.18632/oncotarget.22111.
[30] 王琳钧. 新的肝癌生物标志物的发现[D].厦门:厦门大学,2019.
[31] 裴雨晴. PPP1CA在肝细胞型肝癌中功能及潜在临床应用探讨[D].厦门:厦门大学,2020.
[32] Huang Z, Chu L, Liang J, et al. H19 promotes HCC bone metastasis through reducing osteoprotegerin expression in a protein phosphatase 1 catalytic subunit Alpha/p38 mitogen-activated protein kinase-dependent manner and sponging microRNA 200b-3p[J].Hepatology,2021,74(1):214-232.DOI:10.1002/hep.31673.
[33] Xiang D, Zhu X, Zhang Y, et al. Tribbles homolog 2 promotes hepatic fibrosis and hepatocarcinogenesis through phosphatase 1A-Mediated stabilization of yes-associated protein[J].Liver Int,2021,41(5):1131-1147.DOI:10.1111/liv.14782.
[34] Liu H, Gong Z, Li K, et al. SRPK1/2 and PP1α exert opposite functions by modulating SRSF1-guided MKNK2 alternative splicing in colon adenocarcinoma[J].J Exp Clin Cancer Res,2021,40(1):75.DOI:10.1186/s13046-021- 01877-y.
[35] Sun H, Ou B, Zhao S, et al. USP11 promotes growth and metastasis of colorectal cancer via PPP1CA-mediated activation of ERK/MAPK signaling pathway[J].EBioMedicine,2019,48:236-247.DOI:10.1016/j.ebiom.2019.08.061.
[36] Tian B, Liu J, Zhang N, et al. Oncogenic SNORD12B activates the AKT-mTOR-4EBP1 signaling in esophageal squamous cell carcinoma via nucleus partitioning of PP-1α[J].Oncogene,2021,40(21):3734-3747.DOI:10.1038/s41388-021-01809-2.
[37] de Mello RA, Amaral GA, Neves NM, et al. Current and potential biomarkers in gastric cancer: a critical review of the literature[J].Future Oncol,2021,17(25):3383-3396.DOI:10.2217/fon-2021-0084.
[38] Wu JG, Wang JJ, Jiang X, et al. MiR-125b promotes cell migration and invasion by targeting PPP1CA-Rb signal pathways in gastric cancer, resulting in a poor prognosis[J].Gastric Cancer,2015,18(4):729-739.DOI:10.1007/s10120-014-0421-8.
[39] Ladha J, Donakonda S, Agrawal S, et al. Glioblastoma-specific protein interaction network identifies PP1A and CSK21 as connecting molecules between cell cycle-associated genes[J].Cancer Res,2010,70(16):6437-6447.DOI:10.1158/0008-5472.CAN-10-0819.
[40] Shastry AH, Thota B, Srividya MR, et al. Nuclear protein phosphatase 1 α (PP1A) expression is associated with poor prognosis in p53 expressing glioblastomas[J].Pathol Oncol Res,2016,22(2):287-292.DOI:10.1007/s12253-015-9928-5.
[41] Hang J, Lau SY, Yin R, et al. The role of phosphoprotein phosphatases catalytic subunit genes in pancreatic cancer[J].Biosci Rep,2021,41(1):BSR20203282.DOI:10.1042/BSR20203282.
[42] Hsu LC, Huang X, Seasholtz S, et al. Gene amplification and overexpression of protein phosphatase 1alpha in oral squamous cell carcinoma cell lines[J].Oncogene,2006,25(40):5517-5526.DOI:10.1038/sj.onc.1209563.
[43] Cai H, Xu Y. The role of LPA and YAP signaling in long-term migration of human ovarian cancer cells[J].Cell Commun Signal,2013,11(1):31.DOI:10.1186/1478-811X-11-31.
[44] Wang P, Bai Y, Song B, et al. PP1A-mediated dephosphorylation positively regulates YAP2 activity[J].PLoS One,2011,6(9):e24288.DOI:10.1371/journal.pone.0024288.
[45] Liu J, Ren G, Li K, et al. The Smad4-MYO18A-PP1A complex regulates β-catenin phosphorylation and pemigatinib resistance by inhibiting PAK1 in cholangiocarcinoma[J].Cell Death Differ,2022,29(4):818-831.DOI:10.1038/s41418-021-00897-7.
[46] Matos B, Howl J, Jerónimo C, et al. Modulation of serine/threonine-protein phosphatase 1 (PP1) complexes: a promising approach in cancer treatment[J].Drug Discov Today,2021,26(11):2680-2698.DOI:10.1016/j.drudis.2021.08.001.
[47] Zhang Z, Wang ZX, Chen YX, et al. Integrated analysis of single-cell and bulk RNA sequencing data reveals a pan-cancer stemness signature predicting immunotherapy response[J].Genome Med,2022,14(1):45.DOI:10.1186/s13073-022-01050-w.